• Citer

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer

par Vergote, Ignace;Van Nieuwenhuysen, Els;Casado, Antonio;Laenen, Annouschka;Lorusso, Domenica;Braicu, Elena Ioana;Guerra-Alia, Eva María E.;Zola, Paolo;Wimberger, Pauline;Debruyne, Philip P.R.;Falcó, Esther;Ferrero, Annamaria;Muallem, Mustafa Zelal;Kerger, Joseph ;García-Martinez, Elena;Pignata, Sandro;Sehouli, Jalid;van Gorp, Toon;Gennigens, Christine;Rubio, María Jesús
Référence Gynecologic oncology, 174, page (80-88)
Publication Publié, 2023-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
Auteur:	Vergote, Ignace; Van Nieuwenhuysen, Els; Casado, Antonio; Laenen, Annouschka; Lorusso, Domenica; Braicu, Elena Ioana; Guerra-Alia, Eva María E.; Zola, Paolo; Wimberger, Pauline; Debruyne, Philip P.R.; Falcó, Esther; Ferrero, Annamaria; Muallem, Mustafa Zelal; Kerger, Joseph; García-Martinez, Elena; Pignata, Sandro; Sehouli, Jalid; van Gorp, Toon; Gennigens, Christine; Rubio, María Jesús
Informations sur la publication:	Gynecologic oncology, 174, page (80-88)
Statut de publication:	Publié, 2023-07
Sujet CREF:	Obstétrique
	Gynécologie
	Cancérologie
Mots-clés:	Angiogenesis
	Cervical cancer
	Chemotherapy
	Nintedanib
	Recurrent
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:0090-8258
	info:doi/10.1016/j.ygyno.2023.04.028
	info:pii/S009082582300207X
	info:scp/85158029335
	info:pmid/37167896